Katharine N Bossart

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia
    PLoS Pathog 5:e1000642. 2009
  2. ncbi Functional studies of host-specific ephrin-B ligands as Henipavirus receptors
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
    Virology 372:357-71. 2008
  3. ncbi A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
    Jennifer A McEachern
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, Victoria 3220, Australia
    Vaccine 26:3842-52. 2008
  4. ncbi Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, VIC 3220, Australia
    J Virol Methods 142:29-40. 2007
  5. ncbi Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus
    Michelle L Colgrave
    Queensland Bioscience Precinct, CSIRO Livestock Industries, St Lucia, QLD 4067, Australia
    Glycobiology 22:572-84. 2012
  6. ncbi Serotype-independent detection of foot-and-mouth disease virus
    Janine D Muller
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, Victoria 3220, Australia
    J Virol Methods 151:146-53. 2008
  7. ncbi Expression of novel genes encoded by the paramyxovirus J virus
    Philippa J M Jack
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Private Bag 24 Geelong, Victoria 3220, Australia
    J Gen Virol 89:1434-41. 2008
  8. ncbi Developments towards effective treatments for Nipah and Hendra virus infection
    Katharine N Bossart
    Australian Animal Health Laboratory, CSIRO Livestock Industries, Geelong, Victoria 3220, Australia
    Expert Rev Anti Infect Ther 4:43-55. 2006
  9. ncbi Targeted strategies for henipavirus therapeutics
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
    Open Virol J 1:14-25. 2007

Collaborators

Detail Information

Publications9

  1. ncbi A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia
    PLoS Pathog 5:e1000642. 2009
    ..This study is the first successful post-exposure passive antibody therapy for Nipah virus using a human monoclonal antibody...
  2. ncbi Functional studies of host-specific ephrin-B ligands as Henipavirus receptors
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
    Virology 372:357-71. 2008
    ....
  3. ncbi A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
    Jennifer A McEachern
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, Victoria 3220, Australia
    Vaccine 26:3842-52. 2008
    ..The ability to elicit protective systemic and mucosal immunity in this animal model provides significant progress towards the development of a human subunit vaccine against henipaviruses...
  4. ncbi Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, VIC 3220, Australia
    J Virol Methods 142:29-40. 2007
    ..Sera from henipavirus-seropositive animals differentially blocked ephrin-B2 binding, suggesting that detection and differentiation of HeV and NiV neutralizing antibodies can be done simultaneously in the absence of live virus...
  5. ncbi Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus
    Michelle L Colgrave
    Queensland Bioscience Precinct, CSIRO Livestock Industries, St Lucia, QLD 4067, Australia
    Glycobiology 22:572-84. 2012
    ..The structural features of G protein glycosylation were also determined by X-ray crystallography and interactions with the ephrin-B2 receptor are discussed...
  6. ncbi Serotype-independent detection of foot-and-mouth disease virus
    Janine D Muller
    CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, Victoria 3220, Australia
    J Virol Methods 151:146-53. 2008
    ....
  7. ncbi Expression of novel genes encoded by the paramyxovirus J virus
    Philippa J M Jack
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Private Bag 24 Geelong, Victoria 3220, Australia
    J Gen Virol 89:1434-41. 2008
    ..Preliminary studies indicate that the novel TM protein is a type II glycosylated integral membrane protein, orientated with its C terminus exposed at the cell surface...
  8. ncbi Developments towards effective treatments for Nipah and Hendra virus infection
    Katharine N Bossart
    Australian Animal Health Laboratory, CSIRO Livestock Industries, Geelong, Victoria 3220, Australia
    Expert Rev Anti Infect Ther 4:43-55. 2006
    ....
  9. ncbi Targeted strategies for henipavirus therapeutics
    Katharine N Bossart
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
    Open Virol J 1:14-25. 2007
    ..Assessments of protective host immunity and drug pharmacokinetics will be crucial to the further advancement of therapeutic compounds...